Daehwa Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daehwa Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Kukje Pharma Co Ltd
sales of 123.31 billion Korean Won [US$109.50 million]
of which 92%
Reyon Pharmaceutical Co Ltd
(126.25 billion Korean Won [US$112.11 million]
Hyundai Pharmaceutical Company Limited
(130.48 billion Korean Won [US$115.87 million]
of which 88%
Daehwa Pharmaceutical Company Limited reported sales of 122.20 billion Korean Won (US$108.51 million)
December of 2017.
decrease of 14.1%
versus 2016, when the company's sales were 142.29 billion Korean Won.
Contributing to the drop in overall sales was the 47.8% decline
in Medicine Sales, from 62.74 billion Korean Won to 32.77 billion Korean Won.
There were also decreases in sales in
Medical Information System (down 42.5% to 362.35 million Korean Won)
However, these declines were partially offset by the increase in sales of
Medicine Mafufacture (up 9.2% to 85.43 billion Korean Won)
Medicine Material Manufacturing (up 153.4% to 1.71 billion Korean Won)